Skip to content
Disclosery

13F-HR filed by ACUTA CAPITAL PARTNERS, LLC

ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 35 holding rows worth $135,741,726.

Accession
0001104659-23-060173
Filer
CIK 1582844
Filed
2023-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2023

A holdings report, 35 entries on the cover page, a total value of $135,741,726 stated on the cover page (in dollars after the unit check, H1), rows summing to $135,741,726 with VALUE read as dollars as filed, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
APELLIS PHARMACEUTICALS INC03753U106COM290,500$19,161,380dollars as filed
WHITEHAWK THERAPEUTICS INC00032Q104CMN1,849,402$13,389,670dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock1,099,309$13,015,819dollars as filed
CYMABAY THERAPEUTICS INC23257D103COM878,500$7,660,520dollars as filed
Ventyx Biosciences Inc92332V107Common Stock208,500$6,984,750dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM330,000$6,969,600dollars as filed
KURA ONCOLOGY INC COM50127T109Stock565,257$6,913,093dollars as filed
IVERIC BIO INC46583P102COM280,500$6,824,565dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock23,500$5,263,060dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM298,000$5,104,740dollars as filed
BELLUS HEALTH INC NEW07987C204COM632,500$4,554,000dollars as filed
SAREPTA THERAPEUTICS INC803607100COM32,770$4,516,689dollars as filed
VAXCYTE INC COM92243G108Stock120,500$4,516,340dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW121,500$4,371,570dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM168,000$4,273,920dollars as filed
IVERIC BIO INC99D2WLPZ9COM1,500$3,649,500dollars as filedcall
CELLDEX THERAPEUTICS INC99D2DH6V9COM NEW1,000$3,598,000dollars as filedput
ARGENX SE SPONSORED ADR04016X101ADR9,594$3,574,533dollars as filed
GH RESEARCH PLC ORDINARY SHARESG3855L106Stock243,250$1,943,568dollars as filed
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock104,753$1,800,704dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock121,840$985,686dollars as filed
IOVANCE BIOTHERAPEUTICS INC462260100COM153,639$938,734dollars as filed
ALKERMES PLCG01767105SHS31,689$893,313dollars as filed
EYEPOINT INC COM NEW30233G209Stock303,396$891,984dollars as filed
PMV PHARMACEUTICALS INC69353Y103COM154,471$736,827dollars as filed
REZOLUTE INC76200L309COMMON STOCK366,204$703,112dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock30,979$678,440dollars as filed
HORIZON THERAPEUTICS PLCG46188101SHS6,000$654,840dollars as filed
SAVARA INC805111101COM199,031$388,110dollars as filed
Mersana Therapeutics Inc59045L106Common Stock60,000$246,600dollars as filed
VIKING THERAPEUTICS INC92686J106COM14,000$233,100dollars as filed
KEROS THERAPEUTICS INC COM492327101Stock3,575$152,653dollars as filed
HILLEVAX INC43157M102COM6,664$110,156dollars as filed
KINNATE BIOPHARMA INC49705R105COM5,000$31,250dollars as filed
NUVATION BIO INC67080N119WARR90,832$10,900dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-23-060173this filing2023-05-15acceptance time not in the bulk data set